Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
NASDAQ:IRTC
IRTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$55.92 - $128.52
Previous CloseN/A
Volume94.23K
Average Volume (3M)406.58K
Market Cap
$3.21B
Enterprise Value$3.03B
Total Cash (Recent Filing)$8.62M
Total Debt (Recent Filing)$6.25M
Price to Earnings (P/E)―
Beta0.85
Next Earnings
May 01, 2025EPS Estimate
-0.98Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.64
Shares Outstanding31,409,616
10 Day Avg. Volume458,386
30 Day Avg. Volume406,581
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.55
Price to Cash Flow (P/CF)42.70
P/FCF Ratio66.20
Enterprise Value/Market Cap0.94
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.43
Enterprise Value/Ebitda-34.82
Forecast
1Y Price Target
$131.70Price Target Upside29.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
---
Irhythm Technologies News
See All IRTC News
---
Bulls Say, Bears Say
Bulls Say
EarningsIrhythm Technologies posted strong quarterly financial results, surpassing both earnings and revenue expectations, which supports a positive outlook for the stock.
Market ExpansionManagement remains focused on expanding its total addressable market from 6.5M ACMs to 27M patients presenting to their primary care physicians or unaware of an arrhythmia.
PartnershipsThe company is making significant progress with large national accounts and value-based care partnerships, contributing to record new account openings and revenue growth.
Bears Say
Gross MarginGuidance includes the negative impact from tariffs expected to be a headwind to full-year gross margin.
RegulatoryThere is some uncertainty around regulatory remediation efforts, which could impact growth, with 2025 possibly being a year of growth deceleration before re-acceleration in 2026.
TariffsPotential tariff impacts from Mexico and China could negatively affect gross margins by 50 to 75 basis points.
---
Ownership Overview
1.60% Insiders
36.60% Mutual Funds
0.31% Other Institutional Investors
45.22% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IRTC FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest stock price was $55.92 and its highest was $128.52 in the past 12 months.
What is Irhythm Technologies’s market cap?
Irhythm Technologies’s market cap is $3.21B.
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is May 01, 2025 which is in 17 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Feb 20, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.331 by $0.291.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is -0.98.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 31,409,616 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.331. Following the earnings report the stock price went up 6.009%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Currently, no hedge funds are holding shares in IRTC
---
Irhythm Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$131.70 (29.00% Upside)
$131.70 (29.00% Upside)
Blogger Sentiment
Bullish
IRTC Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.10%
12-Months-Change
Fundamentals
Return on Equity
-75.27%
Trailing 12-Months
Asset Growth
115.04%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies, Inc. is a healthcare technology company that specializes in the development of innovative solutions for cardiac care. The company operates primarily in the digital health sector and is known for its flagship product, the Zio service, which is a comprehensive platform for monitoring and diagnosing cardiac arrhythmias. iRhythm's cutting-edge technology combines wearable biosensor devices with powerful data analytics to provide healthcare providers with actionable insights, enabling more accurate diagnosis and improved patient outcomes.
---
IRTC Company Deck
---
IRTC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance for iRhythm in 2024, with significant revenue growth, international expansion, and margin improvements. Despite ongoing regulatory challenges and pricing pressures, the company is positioned for continued growth with strategic initiatives in place. The positive aspects of the call outweigh the challenges, indicating a favorable outlook.Read More>---
IRTC Stock 12 Month Forecast
Average Price Target
$131.70
▲(29.00% Upside)
Technical Analysis
Best Analysts Covering IRTC
1 Year
1 Year Success Rate
7/23 ratings generated profit
1 Year Average Return
-12.01%
reiterated a buy rating 2 months ago
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 30.43% of your transactions generating a profit, with an average return of -12.01% per trade.
---